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Abstract
Temperature is an important physiological parameter of cell biology. The thermal
energy output of cells in vitro can offer insight into cellular processes. Standard
methodology of measuring cellular thermal output has been through microcalorimetry. In
this work, infrared thermography is presented as an alternative to microcalorimetry and
other measurement techniques. An enclosure that controls the temperature of cells and
allows for injection of temperature control of chemical agents and subsequent
measurement of cell temperature using an infrared camera has been designed and tested.
The enclosure was tested with 3T3-L1 adipocytes treated with the β3 adrenergic agonist
CL 316-243 for up to seven days in order to stimulate heat generation.
The optimization of the system was successful in ensuring that large temperature
fluctuations in the design were minimized. It was shown that there was no statistical
difference (p>0.5) in the temperature of empty cell wells treated with vehicle, therefore
significant differences observed in cell studies are due to differences in cellular
metabolism brought about by chemical stimulation. A statistical power test based on the
initial characterization using a 95% confidence interval shows that 3 replicates should be
adequate to detect an average temperature increase of approximately 0.3°C assuming the
treatment standard deviation remained the same as the control blanks.
The enclosure was tested with 3T3-L1 adipocytes treated with the synthetic
agonist CL 316-243 for 0, 4 and 7 days prior to being measured using infrared
thermography and are shown to heat up significantly in some cases. Standard deviations
increased slightly in the cell treatment tests and therefore larger temperature increases
were necessary to establish a significant increase. It was hypothesized that the 7-day

x

treatment would have the largest response, however some of the 4-day treatments were
shown to have statistically significant increases over controls whereas the seven-day
treatments only indicated a tendency of temperature increase over the control. This is
likely due to the desensitization of the cells.
Advances in IR techniques and decreasing cost of IR technology makes it likely
that IR technology use in biotechnology will increase in the future.

xi

Chapter 1: Introduction
1.1 Background
The United States of America and the world in general have seen a marked
increase in the average weight of their populations (World Health Organization 2000;
Bays 2004; Eckel RH 2004). Currently, 64% of the U.S. adult population is considered to
be some form of obese, from overweight to morbidly obese (Pressler 2005). It is believed
that the main causes of obesity are prolonged periods of decreased physical activity and
high fat diets (Schrauwen and Westerterp 2000), but other theories, such as the effect of
dietary intake of monosodium glutamate (Hermanussen, Garcia et al. 2006) are being
investigated. The term “metabolic syndrome” has been coined to describe the problems
that are associated with obesity. The metabolic syndrome is a group of disorders that are
often observed together, including obesity, insulin resistance, glucose intolerance,
hypertension and dyslipidemia (Moller and Kaufman 2005). Soon, the metabolic
syndrome will push cigarette smoke out of its’ place as the number one risk factor for
cardiovascular disease in the US (Gogia and Agarwal 2006) unless treatment and
prevention measures are employed. It is important to maintain a healthy weight to avoid
the negative health aspects of obesity and the possible development of insulin resistance
(Gogia and Agarwal 2006), causing an increase in blood glucose, and ultimately leading
to Type-two diabetes.
In light of the prevalence of these circumstances, investigations into the molecular
causes and effects of obesity have received a tremendous amount of attention in the last
several decades. One item that was thoroughly investigated was the seeming diversity of
1

metabolic efficiency of people. Some people simply use more and store less of the energy
they consume. Researchers therefore have begun searching for a “magic bullet” to tune
the metabolic efficiency in order to control weight and other health factors.
1.2 Metabolic Efficiency
One mechanism suspected to account for the inconsistent metabolic efficiency of
different individuals was based on the plasticity of specific adipose tissue’s energy
consumption. Brown adipose tissue (BAT), which is present in small rodents and infants
of larger mammals, is very rich in mitochondria when compared to normal white adipose.
This buildup of mitochondria and the associated elevated vascularization gives these cells
a distinctive reddish brown color, hence their name (Bengtsson, Redegren et al. 1996)).
Brown adipocytes tend to have multiple small pockets of stored triacylglycerols (termed
multilocular adipocytes), rather than traditional white adipocytes, which at maturity are
typically unilocular. The additional mitochondria allow brown adipose to use more free
fatty acids (FFAs) rather than releasing them into the blood stream to be used by other
tissue. One of the functions of brown adipose tissue is to facilitate nonshivering
thermogenesis, a phenomenon of thermoregulation in small mammals (Carlson and
Cottle 1956; Depocas, Hart et al. 1956; Bukowiecki, Collet et al. 1982; Ashwell, Jennings
et al. 1983; Jacobsson, Stadler et al. 1985; Milner and Trayhurn 1989).
The feature that gives brown adipose its high degree of metabolic flexibility is a
specific protein that is present in the mitochondria of the cells. This protein, initially
termed Thermogenin and later Uncoupling Protein I (UCP1), has a unique function to
uncouple (hence the name) oxidative phosphorylation from mitochondrial proton
transport (Matthias, Ohlson et al. 2000). The proton gradient that is generated from the
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reduction of nicotinamide adenine dinucleotide (NAD+) and flavin adenine dinucleotide
(FAD2+) via the electron transport chain is used to generate heat, instead of facilitating
the ATP Synthase reaction (Figure 1). In addition to this protein, BAT also expresses a
high level of other proteins involved in the transport and beta oxidation of fatty acids,
which contribute to the elevated oxidative capacity of the cells (Cannon and Nedergaard
2004).

Figure 1. The mitochondrial Electron Transport Chain with UCP1 Proton transport chain.
UCP1 bypasses ATP Synthase and creates heat (Nelson 2005).
The idea of some cells having variable degrees of metabolic efficiency led
scientists to hypothesize that if an obese person could have their fat cells altered to be
more like brown adipose tissue, which can produce heat instead of ATP, he/she would
become less metabolically efficient. Less metabolic efficiency would mean that a fewer
number of the consumed calories would be converted into a useable form, as some
energy would be lost to heat. Concordantly, there was a belief that thermoregulation was
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dysfunctional in obese due to under active sympathetic nervous system (the system that
controls fat storage and breakdown and other important metabolic processes, (Trayhurn
2005), but this belief has recently been challenged (Eikelis and Esler 2005), and it is well
established that energy expenditure is higher in obese subjects (Prentice, Black et al.
1986; Bandini, Schoeller et al. 1990; Prentice, Black et al. 1996). Recent studies have
shown a correlation between polymorphisms in UCP2 and UCP3 and obesity onset
(Kawaguchi, Masuo et al. 2006; Masuo, Katsuya et al. 2006), supporting the case of
deficient uncoupling capacity as a causative agent. It has been shown that mitochondrial
dysfunction can cause triglyceride accumulation (Vankoningsloo, Piens et al. 2005) but it
is unclear if this is a causative agent or logical clinical manifestation, as triglyceride
accumulation is a likely outcome of reduced beta oxidative capacity. The potential ability
to pharmacologically control metabolic efficiency led to investigations of brown adipose
tissue, with hopes of controlling differentiation from white to brown adipocytes (as BAT
is rare in adult humans, (Bengtsson, Redegren et al. 1996), as well as BAT activity after
differentiation.
It is presently considered unlikely that brown adipocytes play a significant role in
adult human thermogenesis (Bengtsson, Redegren et al. 1996) because of their small
numbers in adult humans (one brown adipocyte for every 100-200 white adipocytes,
(Oberkofler, Dallinger et al. 1997)). There has been recent evidence of BAT in adult
humans (Nedergaard, Bengtsson et al. 2007), suggesting that obesity treatment using
brown adipose tissue could be viable (Cadenas, Buckingham et al. 1999) but research
with murine models has so far been unsuccessful in producing a safe and effective
therapy for humans (Weyer, Gautier et al. 1999). Other research areas that show promise
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in producing an effective anti-obesity treatment are the examination of the effects of
peroxisome proliferator-activated receptors (PPARs), sterol regulatory binding proteins
(SREBPs), and leptin and other secreted hormones involved in the neuro-hormonal
control of energy use.
Logically, white adipocytes were the next target for research, as less was known
about the cells themselves, and increases in their size and number is the defining
characteristic of obesity. It had been long assumed based on the physiology of white
adipose tissue that the function of white adipocytes was limited to storage and breakdown
of triacylglycerols (TAGs) (Cannon and Nedergaard 2004), while providing thermal and
mechanical insulation for the whole organism. The lipid containing vacuole can comprise
95% of a mature white adipocytes’ volume (Carmen and Victor 2006). It was believed
that white adipose was the end point of a signal pathway; WAT simply stored and
released FFAs when signaled to do so (Krug and Ehrhart-Bornstein 2005). It is now
known that white adipose tissue (WAT) is a complicated endocrine organ that is involved
in a wide variety of vital processes (Krug and Ehrhart-Bornstein 2005).
White adipose tissue is generally not believed to have a significant thermogenic
capacity (Bengtsson, Redegren et al. 1996) and basal adipose energy consumption is
relatively low compared to the brain and other major organs (Heymsfield 2003). This
idea has been challenged (Granneman 2003) based on the observation that restoring β3
adrenergic receptors expression only in BAT of β3 knockout mice does not restore normal
thermogenesis, but restoring β3 adrenoceptors expression in BAT and WAT does (Grujic,
Susulic et al. 1997; Ito 1998). It has also been shown that mice lacking UCP1 still
demonstrate 20-40% of wild-type thermogenesis in response to acute β3 adrenergic
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stimulation (Da-Wei Gong 2000). The idea that white adipose contributes significantly to
the metabolic output of an organism is unlikely, but has persisted due to the
aforementioned studies, and because only BAT and WAT posses β3 receptors and
therefore the effects of stimulation were limited to those organs. It has been shown
however, that there are peripheral effects of acute β3 adrenergic stimulation in muscle
tissue too, likely due to elevated level of plasma free fatty acid (Nakamura, Nagase et al.
2001; Garcia-Roves, Huss et al. 2007).
These observations do not preclude the possibility of WAT adopting features of
BAT upon specific external stimulation. In fact, this has been reported in several
instances including cold exposure and acute β3 adrenergic treatment (Cinti, Cancello et
al. 2002), a diet rich in n-3 polyunsaturated fatty acids of marine origin (Flachs,
Horakova et al. 2005), PPARα activators (Cabrero, Alegret et al. 2001), PPARδ
activators (Wang, Lee et al. 2003), adenovirus mediated expression of PPARγ coactivator
1α (PGC-1α) (Tiraby, Tavernier et al. 2003), hormonal signaling using leptin (Commins,
Watson et al. 1999), and retinoic acid treatment (Tomas, Jimenez-Jimenez et al. 2004;
Mercader, Ribot et al. 2006). It is noteworthy that several of the above examples are
merely stimulation of the same pathway at different points (Nedergaard, Petrovic et al.
2005) and that increased expression of important genes did not necessarily translate into
increased metabolic activity (Thurlby, Wilson et al. 1987).
1.2.1 β Adrenergic Receptors and Agonists
Heat production from BAT and FFA release from WAT is mediated by the
sympathetic nervous system via adrenergic signals (Cannon and Nedergaard 2004).
Adrenergic receptors are broken into two groups; alpha and beta that are both G-(7TM)
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coupled proteins (Kobilka, Matsui et al. 1987). Beta-receptors are classified as such
because they stimulate adenylyl cyclase while alpha-receptors inhibit it. Alpha 2
adrenergic receptors play a role in modulating neurotransmitter release from sympathetic
and adrenergic neurons (Hein, Altman et al. 1999). Beta 3 receptors lack the functional
groups that are typically associated with desensitization (Emorine, Marullo et al. 1989;
Nahmias, Blin et al. 1991). This form follows the function of adrenergic stimulation in
that thermogenesis is often a prolonged requirement for animals. Desensitization would
therefore not be advantageous for the animal, although the expression level of the mRNA
that code for the β3 receptor is transiently down regulated during stimulation (Granneman
and Lahners 1995; Klaus, Muzzin et al. 1995; Bengtsson, Redegren et al. 1996). One of
the reasons that stimulation of these nerves has remained an attractive prospect for
obesity therapy is because the receptors are almost exclusively found in white and brown
adipose (Cannon and Nedergaard 2004) although some undesirable peripheral effects in
other tissues in response to an elevated FFA level in the plasma have been observed
(Nakamura, Nagase et al. 2001).
The three most frequently used β3 agonists are Norepinephrine (NE), CL 316243
(CL) and BRL- 37344 (BRL). NE is frequently used in studies because it bears the most
physiological significance since it is the naturally occurring signal. BRL is a selective β3
agonist; at higher concentrations it will stimulate β2 receptors too. CL is the most acute β3
agonist known so it has been useful in studies aimed at distinguishing the functions of the
β3 receptors (Cannon and Nedergaard 2004). Norepinephrine activates α1 and α2 receptors
as well as β receptors. This is an important distinction and studies using one or the other
should be carefully compared. As it was mentioned earlier, α2 receptors mediate the
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effects of β stimulation by inhibiting adenylyl cyclase. One study that compared the
effects of chronic stimulation of NE and CL found the effects of CL to be much greater
than the effects of NE on total energy expenditure and resting metabolic rate in male
Sprague-Dawley Rats (Atgie, Faintrenie et al. 1998). The studies that have seen the most
pronounced effect on WAT have used CL as their agonist of choice (Langin, Portillo et
al. 1991; Carpene, Galitzky et al. 1993; Galitzky, Reverte et al. 1993; Simard, Atgie et al.
1994; Himms-Hagen, Melnyk et al. 2000; Granneman, Li et al. 2005; Li, Zhu et al. 2005)
and the expression of UCP1 has been observed in WAT after chronic CL treatment
(Nagase, Yoshida et al. 1996; Ghorbani and Himms-Hagen 1997). Chronic stimulation (7
or more days) of white adipocytes with CL has caused a significant portion of the
adipocytes (33%) to express UCP1 (Cinti 2005).
Chronic (several days) β3 adrenergic stimulation with CL in white adipose tissue
has been shown to induce a pro-inflammatory response (Li, Zhu et al. 2005). This
inflammatory response was characterized by the fractioning of the large unilocular TAG
depots into multilocular depots, the biogenesis of mitochondria, and the up regulation of
genes involved in beta oxidation (Granneman, Li et al. 2005). Previously, it has been
shown that differences in mitochondrial content of white adipocytes modulate the
oxidative capacity (Deveaud, Beauvoit et al. 2004). This increase in the number of
mitochondria and expression of beta oxidation proteins should result in an increase in the
amount of free fatty acids (FFAs) the cells can metabolize rather than exporting the FFAs
into the blood stream. These physiological changes in WAT are very characteristic of
BAT (Bengtsson, Redegren et al. 1996) and thus far have only been classified using
histological, morphological (Granneman, Li et al. 2005), and DNA microarray analysis
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(Oana, Homma et al. 2005). Studying this phenomenon using new measurement
techniques such as infrared thermography in vitro will provide some insight to the degree
of inducible heat generation over periods of chronic stimulation in white adipose in real
time. This would be an indication of the contribution of white adipose to β3 agonist
mediated thermogenesis.
1.2.2 Uncoupling Proteins
The uncoupling proteins are inner mitochondrial membrane proteins that all bear
a close sequence homology to UCP1, and were therefore believed to perform a similar
thermogenic role (Boss, Samec et al. 1997; Fleury, Neverova et al. 1997; Gimeno,
Dembski et al. 1997; Gong, He et al. 1997; Solanes, Vidal-Puig et al. 1997). UCP2 and
UCP3 are now believed to enable mild uncoupling to prevent the buildup of reactive
oxygen species (ROS) in the event of depleted electron acceptors and therefore do not
contribute significantly to thermogenesis (Negre-Salvayre, Hirtz et al. 1997; Arsenijevic,
Onuma et al. 2000; Duval, Negre-Salvayre et al. 2002; Ruzicka, Skobisova et al. 2005),
however this role has been disputed (Duval, Camara et al. 2007). There is conflicting
evidence for the role of UCP3 in controlling ROS production. UCP3 deficient studies
show an increase in ROS production and damage (Vidal-Puig, Grujic et al. 2000; Brand,
Pamplona et al. 2002), while UCP3 over expression does not show a decrease in ROS
damage (Brand, Pamplona et al. 2002; Mozo, Ferry et al. 2006). Regardless of the
specific mechanisms of UCP3 action, there are several desirable effects of increased
UCP3 in skeletal muscle such as increased cellular longevity, an increase in metabolic
flexibility and increased insulin sensitivity (Bezaire, Seifert et al. 2007).
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In contrast to UCP1, which is primarily expressed in BAT (Nicholls and Locke
1984; Nicholls and Rial 1999; Nedergaard, Golozoubova et al. 2001), UCP2 is expressed
in a wide range of tissues including WAT and skeletal muscle (Fleury, Neverova et al.
1997), and UCP3 is expressed in skeletal muscle and the female reproductive tract
(Vidal-Puig, Solanes et al. 1997; Rousset, Alves-Guerra et al. 2003). UCP2 mRNA
expression levels are not accurate predictors of protein levels, as some tissues that
transcribe the UCP2 gene show no trace of the protein using antibody detection
techniques (Sivitz, Fink et al. 1999; Pecqueur, Alves-Guerra et al. 2001).
UCP3 was initially viewed with a great deal of interest because of its expression
in skeletal muscle, and the high estimates of energy usage that was attributed to
uncoupling (Stuart, Cadenas et al. 2001). UCP3 was thought to facilitate basal proton
leak, a previously discovered phenomenon in muscle (Brand 1990) however this was
disproved and it is now believed that proton leak is enabled by the adenine nucleotide
transporter (Cadenas, Buckingham et al. 1999; Bezaire, Hofmann et al. 2001; Brand,
Pakay et al. 2005).
It has been assumed thus far that the main action of the uncoupling proteins is to
transport protons across the inner mitochondrial membrane, but other mechanisms such
as fatty acid cycling/buffering have been suggested (Nicholls and Lindberg 1973;
Winkler and Klingenberg 1994; Garlid, Orosz et al. 1996; Klingenberg and Huang 1999)
and controversy remains over UCP mechanisms under physiological conditions (Garlid,
Orosz et al. 1996; Gonzalez-Barroso, Fleury et al. 1998; Jezek, Engstova et al. 1998). The
proton-buffering model postulates that protons are transported through UCP1 with the
help of proton buffering amino acids, and fatty acids would function to donate protons to
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the proton channel (Winkler and Klingenberg 1994; Klingenberg and Huang 1999). The
fatty acid cycling model states that UCP1 facilitates transport of deprotonated fatty acids
out of the mitochondrial membrane so that they may be protonated and freely transported
back into the inner mitochondrial space (Skulachev 1991; Jezek, Orosz et al. 1994;
Garlid, Orosz et al. 1996; Garlid, Jaburek et al. 1998; Jaburek, Varecha et al. 2001). Both
mechanisms are congruent with the general model of fatty acid activation of UCP1
activity, but controversy remains as strong arguments have been made for and against
both models (Gonzalez-Barroso, Fleury et al. 1998; Garlid, Jaburek et al. 2000; Garlid,
Jaburek et al. 2001; Rial, Aguirregoitia et al. 2004).
UCPs have been shown to be inhibited by phosphorylated purine nucleotides such
as ATP, ADP, GTP and GDP but not purine nucleotide monophosphates (AMP, GMP)
(Heaton, Wagenvoord et al. 1978; Nicholls 2001). This mechanism is only hypothesized
to exist in vivo, as only a limited amount of evidence for in vivo activity has been
reported (Hagen, Zhang et al. 2000). Regardless of the mechanisms, UCP2 and UCP3 do
not under normal circumstances contribute to nonshivering thermogenesis but UCP3 may
be thermogenic under certain circumstances and could therefore be a target of
pharmaceutical modulation (Echtay 2007). It is worth noting the two other UCPs, UCP4
and UCP5 that have a lower sequence homology to UCP1 and are hypothesized to also
modulate ROS generation (Echtay 2007).
1.2.3 PPARs
The Peroxisome Proliferator Activated Receptors (PPARs) are members of the
nuclear receptor superfamily of ligand inducible transcription factors (Desvergne and
Wahli 1999; Kersten, Desvergne et al. 2000; Evans, Barish et al. 2004). When the
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external ligand binds the receptor, it then binds with the retinoid X receptor (RXR) to
form a heterodimer. This heterodimer, with the bound ligand, acts as a transcription
factor, controlling the expression of a set of genes; it does this by binding directly to the
PPAR response element (PPRE), a specific DNA sequence composed of direct repeats
separated by one base pair. Gene target specificity of transcription factors is achieved by
differences in the recognition sequence, the receptor configuration (i.e. heterodimer, a
homodimer or a monomer), and the number of base pairs that separate the repeats
(Aranda and Pascual 2001). The order of the response elements also contributes to
specificity, as they can be arranged as palindromes, direct repeats, or inverted
palindromes (Aranda and Pascual 2001). In the absence of a ligand, the PPAR-RXR
heterodimer engage in active gene silencing by recruiting co-repressors, histone
deacetylases and chromatin modifying enzymes (Ordentlich, Downes et al. 2001; Jepsen
and Rosenfeld 2002; Privalsky 2004). When PPARs bind to their ligands, which are
dietary lipids, the heterodimer goes through a conformational change and then binds with
transcriptional activators, encouraging gene transcription (Smith 1997; Bocher, PinedaTorra et al. 2002). The genes that are regulated by the PPARs are related to lipid
metabolism, storage and transport and together are thought to coordinate lipid and
carbohydrate metabolism (Semple, Chatterjee et al. 2006).
There are currently three known PPARs: PPARα, PPARγ, and PPARδ. PPARγ is
expressed predominantly in adipose tissue and is important for regulating adipocyte
differentiation and lipid accumulation (Sandouk, Reda et al. 1993; Tontonoz, Hu et al.
1994; Rosen and Spiegelman 2000; Ren, Collingwood et al. 2002; Rosen, Hsu et al.
2002). PPARγ is the target of a class of drugs called the thiazolidinediones (TZDs),
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which are insulin sensitizing anti-diabetic drugs (Forman, Tontonoz et al. 1995;
Lehmann, Moore et al. 1995). These drugs have also effected brown adipose recruitment,
differentiation and increased UCP1 expression (Mercer and Trayhurn 1986; Rothwell,
Stock et al. 1987), but β stimulation was required to produce changes in metabolism
(Thurlby, Wilson et al. 1987). Alternatively, proteins inhibiting PPARγ degradation
rather than stimulating expression or activity has been described (Floyd and Stephens
2004).
PPARα is expressed mostly in the liver, kidney, BAT, muscle and heart tissue
and has been shown to coordinate the metabolic response to fasting by activating βoxidation (Semple, Chatterjee et al. 2006). PPARα also controls gluconeogenesis
(Patsouris, Mandard et al. 2004), biotransformation (Barbier, Villeneuve et al. 2003), and
cholesterol metabolism (Lefebvre, Chinetti et al. 2006). PPARα receptors respond to
synthetic fibrates as well as unsaturated fatty acids and eicosanoids. While genetic
knockout studies implicate PPARα in a lipid regulating, anti-obesity role (Costet,
Legendre et al. 1998; Guerre-Millo, Gervois et al. 2000; Mancini, Lanni et al. 2001;
Vazquez, Roglans et al. 2001), it is unclear how this is facilitated (Stienstra, Duval et al.
2007). Regardless of the method of action, drugs that target these two receptors are in use
and attempts to create new ones are ongoing, including a new set that target different
combinations of the PPARs (Sharma 2008).
Until recently, little was known about PPARδ (Fredenrich and Grimaldi 2005),
despite the fact that it was cloned in 1992 (Dreyer, Krey et al. 1992; Schmidt, Endo et al.
1992). It is poorly understood because it was not expediently investigated as it was
shown to be widely expressed and therefore assumed to be an inferior pharmaceutical
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target. What has been discovered is that with the increased expression profile came an
increased functional profile. PPARδ is expressed in BAT, WAT, skeletal and cardiac
muscle and acts to upregulate fatty acid transport and oxidation, thermogenesis (including
UCP1 expression in WAT), and oxidative metabolism proteins in these tissues (Holst,
Luquet et al. 2003; Tanaka, Yamamoto et al. 2003; Wang, Lee et al. 2003; Wang, Zhang
et al. 2004; Abbot, McCormack et al. 2005; Barish, Narkar et al. 2006; Garcia-Roves,
Huss et al. 2007). Murine receptor knockout models have produced several side effects
including embryonic lethality, reduced adipose stores, myelination defects, modulated
inflammation responses in skin, and impaired wound healing (Peters, Lee et al. 2000;
Tan, Michalik et al. 2001; Barak, Liao et al. 2002). PPARδ is activated by a variety of
saturated and polyunsaturated fatty acids in addition to several synthetic and natural
eicosanoids (Yu, Bayona et al. 1995; Forman, Chen et al. 1997; Krey, Braissant et al.
1997; Xu, Lambert et al. 1999). The synthetic agonist GW501516 is the most widely
tested and has been shown to induce β oxidation in skeletal muscle and adipose and UCP
1 expression in WAT (Wang, Lee et al. 2003). This combination is useful as an antiobesity drug, as shifts toward lipid metabolism in a significant portion of the body is
necessary to ensure that a healthy amount of circulating lipid is maintained. It also acts to
couple lipid mobilization and lipid usage and avoids side effects of other hormonal
treatments such as loss of lean body mass and cardiac toxicity or excessive plasma FFAs
levels (Wang, Lee et al. 2003).
There is presently an incomplete understanding of the PPARs and the above
description of the PPARs is an extreme simplification of the existing knowledge. It is
intended to give a brief overview into the general effects and activities of the molecular

14

mechanisms involved in cellular heat generation in order to illustrate that there is an
abundance of molecular targets for adaptive thermogenesis.
1.2.4 PGC-1α/β
The PPARγ coactivator 1 α/β are transcription regulators that were shown to have
an influence over transcription in a wide range of tissues (Giguere 2002; Wang, Lee et al.
2003; Lin, Handschin et al. 2005; Finck and Kelly 2006). PGC-1α and PGC-1β have
homologous sequences and are suggested to have a degree of overlapping or redundant
functionality (Kressler, Schreiber et al. 2002; Lin, Puigserver et al. 2002; Uldry, Yang et
al. 2006), however this redundancy has been recently challenged (Sonoda, Mehl et al.
2007). PGC-1α has been shown to activate adaptive thermogenesis by regulating genes
related to mitochondrial biogenesis and oxidative respiration (Puigserver, Wu et al. 1998;
Wu, Puigserver et al. 1999; Lehman, Barger et al. 2000; Vega, Huss et al. 2000; Kelly
and Scarpulla 2004; Lin, Handschin et al. 2005). It seems that PGC-1α regulates energy
homeostasis in cells as when it is over expressed it causes an increased mitochondrial
biogenesis and improves efficiency of the existing mitochondria through gene regulation
(Wu, Puigserver et al. 1999; St-Pierre, Lin et al. 2003). Conversely, knockout models
produce metabolic and performance deficiencies (Lin, Wu et al. 2004; Leone, Lehman et
al. 2005; Sonoda, Mehl et al. 2007). It has been shown that chemical uncoupling of
oxidative phosphorylation induces PGC-1α genes and subsequently other genes required
for oxidative respiration (Rohas, St-Pierre et al. 2007).
1.2.5 Retionic Acid
Retinoic acid is a form of vitamin A that has been shown to have anti-obesity
effects in mice, including UCP1 expression (Puigserver, Vazquez et al. 1996; Bonet,
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Oliver et al. 2000; Ribot, Felipe et al. 2001; Felipe, Bonet et al. 2004; Mercader, Ribot et
al. 2006), however, expression has not manifested in cultured models, implying an
indirect signal (Mercader, Madsen et al. 2007). Retinoic acid regulates gene expression
by targeting the Retinoid X Receptors (RXRs) and the retinoic acid receptors (RARs)
(Bastien and Rochette-Egly 2004). There have also been reports of retinoic acid directly
effecting protein activity (Bost, Caron et al. 2002; Teruel, Hernandez et al. 2003). The
anti-obesity effects have been similar to the ones reported in PPARδ, i.e. increase in
expression of genes involved in fatty acid oxidation and transport in WAT, BAT and
skeletal muscle (Mercader, Ribot et al. 2006; Amengual, Ribot et al. 2008).
1.2.6 Adipokines
In addition to the previously described cell surface receptor pathways and
transcriptional activators, there is another class of biological molecules that play a large
role in energy balance and lipid accumulation called adipokines. Adipokines tend to
coordinate hormonal signals of appetite, satiation and overall metabolism and they
originate from adipose tissue. As these therapies do not aim to induce thermogenesis,
they will only be partially reviewed here.
Leptin was one of the first known adipokines, and is predominantly secreted by
WAT (Zhang, Proenca et al. 1994). Circulating levels of leptin correlated with total body
fat and it was shown that pharmaceutical modulation of leptin could reduce body fat in
mice (Halaas, Gajiwala et al. 1995; Maffei, Halaas et al. 1995; Halaas, Boozer et al.
1997). This model of energy regulation turned out to be incomplete, as tests on obese
subjects revealed little change when administered leptin as subjects tended to develop a
resistance to elevated leptin levels (Considine, Sinha et al. 1996).
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The aforementioned molecular targets are all of interest for the pharmaceutical
modulation of metabolic efficiency and their effects on specific tissue heat generation are
of interest. The β3 agonist CL 316243 is expected to have the largest effect on cultured
white adipocytes and was therefore chosen for this initial study.
1.3 Cellular Heat Measurement Techniques
1.3.1 Microcalorimetry and Oxygen Consumption
The metabolic output of living cells in the form of dissipated heat is an important
physiological factor that has been studied extensively using several different techniques.
The study of thermal output of cells has the prospect of yielding several practical
applications in medicine; a recent example is using microcalorimetry to more rapidly
diagnose meningitis (Trampuz, Steinhuber et al. 2007). Cell heating data has also been
useful in optimizing cell culture media formulation (Kemp 2001) and can be used to
monitor cell culture health as it has been shown that cell heat output is a leading indicator
of cell growth (Kemp 1997). The most common method to measure this parameter has
been the use of microcalorimetry. Microcalorimeters have very high thermal sensitivity
and have been used to quantify the total metabolic output of a variety of cells under
various conditions (Kemp 1991; Kemp 1996; Kemp 2000). Additionally,
microcalorimeters have been useful in the fields of biocompatibility, ecology, and other
areas of science (Wadso 1995). The evolution of commercial microcalorimeters has been
important for the adoption of the technology for new applications.
Isothermal titration calorimetry uses two insulated cell culture chambers
surrounded by thermopiles that both measure and maintain the temperature in the vessel
(Wadso 2001). The system monitors the energy consumption required to keep the
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treatment and control vessel at the same temperature during the introduction of some
reagent. Microcalorimetry has a very high thermal resolution (Wadso 2001), but a low
spatial resolution. Smaller vessels have allowed for reduced sample sizes in order to
improve temporal response, but these systems are less than ideal for recording highly
accurate kinetic data during fast temperature fluctuations as any temperature changes
must be transferred through conduction to the measurement thermopiles (Wadso 1995).
Microcalorimetric studies tend to require lengthy and complicated setups and frequent
calibration, which can be even more complicated when used simultaneously with O2
measurement. Other disadvantages of microcalorimeters include errors due to gas
permeability of tubing, damage to the cells during pumping, vessel biocompatibility,
inappropriate stir rates for batch type devices and inappropriate flow rates for flow
through calorimeters (Kemp 1997).
Despite these challenges, a large volume of information about the specific heat
generation per cell has been reported for a wide variety of biological materials. The heat
flux values range from 0.01 pW/cell for human erythrocytes to 329 pW/cell for rat
hepatocytes (Kemp 1997). While this basal heat flux data is important, what is often more
useful for practical application is the heat flux response due to some pharmacologic
stimulation or during a relative scarcity of some important metabolite.
1.3.2 Thermal Lens Microscopy
Methods have been described to indirectly measure the temperature of single
intact cells using a thermal lens technique. This procedure involves irradiating a cell with
a pulsed laser to heat cellular components, followed by measurement of thermal
relaxation times. Relaxation time is measured optically as cells change their refractive
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index, which is detected by an additional probe laser beam (Zharov 2005). This technique
has been used to measure the redox state of single cells (Lapotko, Romanovskaya et al.
2002a) and the response of cells in the presence of a drug (Lapotko, Romanovskaya et al.
2002b). The underlying assumptions in those reports are that the relationship between
laser absorbance and temperature increase is linear and that no laser light is absorbed in
other processes such as protein coagulation/denaturation, bubble formation, or other
chemical phenomena. This technique is able to avoid using fluorescent dyes or
chromaphores, but relies instead on measuring laser-induced changes of the cell’s
geometry due to thermal expansion rather than native induced changes in cells.
1.3.3 Thermal-Sensitive Dyes and Other Methods
Techniques to measure the temperature of cells using various thermally sensitive
agents have been reported. Europium (III) thenoyltrifluoro-acetonate has been used to
image cell surface heating responses (Zohar, Ikeda et al. 1998; Suzuki, Tseeb et al. 2007),
while other studies have attempted to use other thermally sensitive fluorophores to detect
temperature changes (Chapman, Liu et al. 1995). The use of thermo-sensitive
fluorophores can produce three-dimensional images using two-photon imaging (Van
Keuren 2004). These methodologies require the addition of a thermo-sensitive dye to the
cell culture which could have unintended effects on cell metabolism as they require
excitation with a laser or UV flash. These methods are also subject to photobleaching and
thermobleaching of the signal that must be accounted for and calibrated into the system.
Additionally, there may be heating effects from the excitation source that should be
accounted for.
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The use of a miniature thermocouple has also been reported to directly measure
the temperature of a single cell (Watanabe, Kakuta et al. 2005). The thermocouple was
fabricated directly onto a glass micropipette, which was used to both inject a cell with a
chemical substance and to measure the subsequent thermal effect. This measurement
method is prone to the thermal conductivity errors in which the thermocouple and pipette
material transports heat (Holman 2000). One of the more sophisticated techniques for
measuring the temperature of a small group of cells has involved thin film
nanofabrication and silicon micromachining of a small thermoelectric chip (Johannessen,
Weaver et al. 2002). The chip has a small well for cells that is surrounded by a reference
heater keeping the cells at physiological temperature. The reference heater is also
surrounded by an array of thermocouples to measure outward heat flux. This device was
used to measure the heat output of a small mass of cells (Johannessen, Weaver et al.
2002).
1.4 Infrared Thermography
Infrared thermography is a technique of temperature measurement that relies on
the natural emission of electromagnetic radiation of objects, which is usually maximum
in the IR range of the spectrum. All physical objects emit electromagnetic waves in the
mid-infrared (MIR) region of the spectrum and the emitted energy intensity is directly
correlated with the temperature of the material and the emissivity of the surface of the
material. Max Planck first described the blackbody emission and the equation that
describes this phenomenon (Holman 2000):
2π hc 2
Wλb =
⎛ hc
⎞
λ 5 ⎜ e λ kT − 1⎟
⎝
⎠
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Where: Wλb - blackbody spectral radiant emittance at wavelength λ; c - speed of light
(m/s); h - Planck’s constant (6.6 x 10-34 Joule seconds); k - Boltzmann constant (1.4 x 1023

Joule/K); T is the absolute temperature of a blackbody, and λ is wavelength.
The formula specifies that as temperature decreases, the peak spectral radiant

emittance occurres at a higher wavelength. This explains how we can only “see” the
temperature of very hot things (e.g. the coil on an electric stove), the maximum emittance
of cooler objects have wavelengths which are above the visual range. By integrating the
Planck equation, Stefan and Boltzman yielded a formula that establishes a relationship
between radiant emittance and temperature of an object that also depends on the emissive
properties of the material.

Wb = εσ T 4
Where: Wb - total radiant emittance of a blackbody, σ - Stefan-Boltzmann constant (5.669
x 10-8 W/m2 K4), T - absolute temperature; and ε - emissivity of the object surface (the
ratio of the emissive power of the object to the emissive power of a blackbody at the
same temperature).
This correlation, along with highly sensitive photodetectors in the IR spectrum,
allow for very good spatial, thermal and temporal resolution without interfering with the
sample, as the measurement is performed remotely. The high spatial resolution allows for
the measurement of many samples at once and therefore can be used in high throughput
screening of the effects of pharmaceuticals on a cell population. This methodology was
initially demonstrated by Paulik et. al., using transgenic yeast and brown adipocytes
(Paulik, Buckholz et al. 1998). The yeast cells tested were transformed to express
uncoupling protein 1 which uncouples oxidative phosphorylation from ATP generation
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making the yeast cell biochemically similar to brown adipose tissue (BAT). Brown
adipose tissue generate heat in small mammals through non-shivering thermogenesis and
is known to be one of the most proficient heat producing tissues (Kemp 1997). For
infrared thermography to be a viable technique for receptor-activated heat detection, it
would need to detect heating from cells that do not produce as much heat as brown
adipose, as BAT is uncommon in most research models and is not present in significant
quantities in adult humans. A similar technique has been used for substrate specificity
screening in biochemical reactions (Millot 2002). The use of infrared thermography as a
cell measurement tool in cellular biology could play an important role in high throughput
screening of various biochemical derivates of anti obesity compounds and their effects on
cellular functions and metabolism.
White adipose cells, in contrast to brown, are at the lower end of the heat
producing power (49 pW/cell as opposed to 110 pW/cell for brown adipose) and the
cultured murine model (3T3 L1), often used as a white adipose tissue (WAT) substitute
in research, is even lower (17 pW/cell) (Kemp 1997). The pharmaceutical influence on
the 3T3-L1 adipocytes has been well classified and the cells have been shown to be
metabolically adaptive. In microcalorimetry studies, WAT harvested from humans
displayed a heat production increase of 39.9% above basal upon insulin stimulation
(Bottcher and Furst 1996) and a 55% increase under beta adrenergic stimulation
(isoprenaline, a selective β1, β2 agonist) (Bottcher and Furst 1997a). Other
microcalorimetry studies performed on white adipocytes have observed appreciable heat
generation. Sorbris et. al., (Sorbris, Monti et al. 1982) and Bottcher et. al., (Bottcher and
Furst 1997b) both observed that heat production from adipose tissue in lean people was
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higher than observed in adipocytes harvested from obese people. In murine models,
Nilsson-Ehle et. al. (Nilsson-Ehle and Nordin 1985) observed that isolated adipocytes
displayed an increase in heat production upon the introduction of insulin and glucose.
The attenuation of metabolic output based on temperature measurement could be
therefore used as another tool for screening novel drugs created as a treatment for
obesity. This information could be useful in identifying lead compounds from an
assortment of chemical derivatives.
In addition to microcalorimetry, measurement of oxygen consumption has been
commonly analyzed to directly determine metabolic activity occurring during oxidative
phosphorylation. In one study it was observed that WAT had volumetric O2 consumption
rates 7 to 8 times lower than BAT when treated with insulin and triiodothyronine in cells
cultured from the same animal under the same circumstances (Klaus, Ely et al. 1995). If
these results are then linearly correlated to the infrared thermography study performed by
Paulik, et al., (Paulik, Buckholz et al. 1998) on BAT which observed a temperature
increase of 0.8 ◦C after acute β3 stimulation, then there should be at least a 0.16 ◦C change
in temperature of similarly treated WAT.
To measure such small temperature differences it is necessary to fully insulate the
sample and to reduce or even eliminate outside temperature influences. This necessitates
the control of sample injection, in order to minimize the thermal effects of the fluid itself.
The purpose of this study was to design and test a device and procedure that allows
remote temperature measurement of very small temperature changes during chemical
stimulation of cells for detection of increased metabolic activity. Such information could
be useful for evaluating potential lead compounds for treating metabolic disorders.
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Once the setup was validated, cell tests were performed using 3T3-L1 cultured
adipocytes. The goal of the study was to try to reproduce the remodeling effects that have
been previously reported by treating the cells chronically with a potent β3 agonist for
seven days. Chronic treatment, as opposed to a single dose, should have the effect of
increasing the overall metabolic capability of the cell and therefore the total heat output.
The goal is to validate the method of heat measurement with a cell model and show that
detection of heat is possible with cells that are not conventionally thought to release
significant amounts of energy in the form of heat.
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Chapter 2: Device Description and Validation
2.1 Materials and Methods
2.1.1 Construction
A closed, insulated chamber was constructed to shield the cells and camera from
outside temperature effects and from external infrared radiation sources that could effect
measurements (Figure 2). The opening in the side is for accessing the chamber to insert
and remove the cell plate. This opening is normally closed with an insulation block
designed to fit in the opening. Cell culture plate and sample injection temperature control
was integrated into the design of the chamber. Temperature control was achieved by
placing thermoelectric heaters (Peltier plates) adjacent to aluminum blocks to evenly
transfer the heat to the cell plate, and injection syringes such that all components are at
the same temperature. The cell culture dish rests on an aluminum block in the center of
the chamber, while two separate aluminum blocks house injection syringes oriented to
introduce samples directly into the cell plates (Figures 3 and 4). The injection syringes
are positioned symmetrically on both sides of the cell culture plate so that each of the six
cell wells can be injected independently and/or simultaneously. This design allows one
side of the cell well to be treated with the agonist of interest and the other with a control
vehicle so that the induced effect can be calculated from a differential measurement. The
treatment and control wells can also easily be randomized in this arrangement. The
camera (FLIR SC 500, FLIR Systems Inc., Boston, MA) is positioned 0.3048 m (one
foot) directly above the cell plate at the minimum focusing distance while still being able
to simultaneously image all six of the cell culture wells. The injection syringe block can
be positioned near to the cell well during injection and then retracted such that the
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syringes did not obstruct the camera’s field of view. Thermal images were acquired at a
rate of 1 per second using the Thermacam Researcher software (FLIR Systems Inc.,
Boston, MA) and images were saved as SEQ files. The thermal image analysis was
performed using the Thermacam Researcher software and by embedding a VBA macro
(Appendix A) into Microsoft Excel (Microsoft Corp., Redmond, WA) to extract and
analyze the data.
The chamber casing was made out of 0.5 inch sheets of R3 Styrofoam (Figure 2).
Sheets were cut to desired dimensions and layered on top of each other within a steel
frame. The Styrofoam was used because it is readily available, cost effective, easy to
work with, and provided the necessary thermal insulation.
Infrared
Camera

Opening for
sample access
(closed during
experiments)
Support
Frame

Injection
block

Figure 2. Autocad rendering of the design.
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Camera

Injection
Syringes

Support
Frame
Cell wells

Insulation

Figure 3. Top perspective of the design with most of the insulation removed to illustrate
component configuration.

Injection
syringes

Cell culture plate
Insulation

Heating plate
Figure 4. Transparent front perspective Autocad rendering of the design.
2.1.2 Electronic Control Module
A BASIC Stamp (Model# BS2P40,Parallax Inc., Rocklin, CA) module was used
as the main temperature controller. A small circuit (Figure 5) was designed to convert
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the output signal of the BASIC Stamp into a 12-volt signal that activated a set of relays
that powered thermoelectric modules (Peltier Plates). Thermistors were implanted into
each of the aluminum blocks to provide a temperature feedback to the BASIC Stamp.
The temperature feed back was achieved by using a small RC time circuit that charged a
capacitor to 5 volts and measured the amount of time it took for the capacitor to
discharge, which is dependent on the thermistor’s resistance. A temperature value is
calculated from the discharge time and used to control the power to the peltier plate. The
aluminum blocks are also independently monitored by a set of thermocouples attached to
a datalogger (model: TC-08 (USB) PicoTech, Cambridgeshire, UK). Details are provided
in Appendix B.
The temperature is maintained between below 37 °C and above 34 °C. To ensure
that the cells are slightly below the physiological temperature range. This is done so that
any increase in temperature would be measurable and so that cells would be close enough
to physiological temperature to keep proteins and molecular machinery operating
optimally. There may be differences in temperature between cells maintained at 30 °C
versus 38 °C.
2.1.3 Validation Testing Procedures
To validate the design and construction of the measurement setup, several
iterations of testing and optimization were performed. These control tests used empty sixwell cell plates and water solutions. Empty cell plates were injected with 10 µl of
nanopure water and recorded with the infrared camera. These tests were performed to
characterize the system behavior without cells or treatment compounds. Ideally, these
control experiments should yield very consistent results with all recorded well
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six
Figure 5. Circuit diagram of temperature control unit.
temperatures being similar. Prior to injection, it is important that the injection blocks
have the same temperature, which is verified with the thermocouple data logging system.
The experiments were performed to determine the thermal inconsistencies/differences
between different plates location, followed by optimization and adjustment of the
hardware and control procedures.
2.2 Results
Several initial tests were completed to determine if any temperature fluctuations
or heating patterns existed inherently in the design. The tests revealed a repeatable
difference in temperature, with the treatment side being warmer than the control side
even in the absence of cells and agonist (Figures 6 & 7). Further tests were performed
with the temperature controller on and off after injection to determine whether there were
significant differences between the two configurations. The tests with the power off show
an initial spike after injection then a gradual cooling (Figure 6). The treatment side
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contains wells 1, 3 and 5 (red and orange) and the control side consists of wells 2, 4 and 6
(blue). After injection into an empty cell plate with water, the power to the plates was cut
off, which accounts for the downward trend. The average value for each well is presented
in the top corner of figure 6. The average values are color coded to match their respective
well and placed in a similar configuration to how they appear on the camera. It is
apparent from this chart that the control side was consistently cooler than the treatment
side despite there being no difference in treatment. The power on tests (Figure 7) see
these same trends with an eventual return to higher temperatures as the sample is
evaporated. In both sets of data the treatment wells were warmer than the control wells.
The physical design was examined for the possible causes of the temperature
irregularities observed in figures 6 and 7. A small air draft was identified in the unit and
was repaired. Five subsequent trials with the power on failed to show any improvement
over the previous tests, with the control side still cooler than the treatment side (Figure
8). A secondary investigation of the physical design revealed that the aluminum block
supporting cell plate was not sufficiently insulated from the steel bar supporting the
camera. After padding an immediate effect was an increased temperature of the
aluminum cell plate. This change necessitated an adjustment of the set point on the
temperature control unit as the cell plate was now hotter than the injection plates. The
insulation of the camera support bar had the desired effect of reducing temperature
fluctuations (Figure 9), with no major outliers and greatly reduced variance (Table 1).
The row marked “split” is an indicator of the average temperature of the treatment wells
vs. the control wells. It is computed by dividing the average of the treatment wells from
the average of the control wells and then subtracting 1. This gives a positive or negative
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Figure 6. Average well temperatures for four separate trial runs with the temperature
controller off.
value that is proportional to the difference between the wells. Positive numbers indicate
tests where the treatment wells were hotter on average while negative values indicate a
test where the control wells were hotter. Statistical analysis showed that there was no
difference (p>0.05) between the control and treatment side.
To determine if these thermal effects are from temperature inconsistencies in the
heating plates, an infrared imaging test was run with no cell plate present. Temperature
images were recorded every second and data was extracted from the area over the peltier
plates, and from the entire area (Figure 10).
After the data was extracted, it was apparent that there was very little measurable should
receive equal temperature and therefore any differences between different cell plates
should be due to differences in emissivity and reflectivity. There was also no
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difference between the two sides of the aluminum plate where the treatment and control
cell plates rest (Figures 11 & 12).

Figure 7. Average well temperatures for three separate trial runs. After injection into an
empty cell plate with water, the power to the plates was kept on, which accounts for
the upward trend.
2.3 Discussion
The results of our experiments suggests that the thermal inconsistency within the system
have been minimized and that the statistical difference between well locations is very
close to zero. This provides the best possible environment for sensing the receptor
activated heat release in cell cultures, as any temperature change recorded would be due
to metabolic heat production rather than due to uncertainties in the measurement setup.
Another step that could be used to mitigate any further or unresolved thermal
inconsistencies would be to randomize the treatment and control wells instead of
restricting them to one side of the cell well.
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Figure 8. Average well temperatures for four separate trial runs (n=4).
difference between the different areas (Figure 11). This indicates that the cell plates

Figure 9. Average well temperatures for three separate trial runs (n=3).
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While the described modifications to the enclosure were able to remove thermal
inconsistencies between the statistical means of the treatment and control sides, closer
evaluation of the data reveals that the control side did have a larger range of values
(Figure 13). This could indicate that further insulation of the enclosure may facilitate
better results.
Table 1. Summary of all results.

Total area

Treatment
side

Peltier plate
Control side

Figure 10. Infrared image of aluminum plate that is used to heat cells.
The total average temperature for all wells over the entire experiment was 34.18 °C and
the standard deviation for the same data was 0.17 °C. It has been reported that adherent
BAT treated with CL were observed to have a 0.8°C increase (Paulik, Buckholz et al.
1998).
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Figure 11. Average temperature values for the aluminum heating plate for the areas
indicated in Figure 10. The temperatures are so close that their plots completely
overlap.

Figure 12. Average temperatures of the treatment vs. control side.
These cells were not aspirated so a large amount of energy was required to increase the
temperature of the media that was measured. Based on a power test using the standard
deviation of the data reported here, the enclosure should be able to establish
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Figure 13. Control and treatment means vs. individual well means.
significance with only 3 samples for an increase of approximately 0.3 °C, assuming
standard deviation remains small for the cell tests.
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Where n is the sample number, tα/2 is the t chart value for a 95% confidence interval with
5 degrees of freedom, tβ is the t chart value for a beta of 0.2, s is the standard deviation of
the sample, and E is the expected difference between treatment and control.
The data collected here suggests that the enclosure should be able to detect
changes in cellular thermal output with a relatively small sample size. However, the
sensitivity is still relatively small compared with microcalorimetry which can be in the
range of mK (Wadso 2001). Based on the results of previous IR studies, this high degree
of sensitivity is not required for testing receptor activated heat generation of large groups
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of adherent cells, and the speed and ability of IR to measure many samples at once with
little preparation is preferable.
This design yielded a viable method for measuring thermal effects in cells quickly
and easily. Programming and data analysis can be streamlined with the use of Visual
Basic (Microsoft, Redmond, WA) macros and pre-designed templates. Additionally, the
chamber design could be scaled-up to use cell plates with more wells. The rapid
processing of many samples with controls and with varying concentrations
simultaneously within a single test would be preferred over existing techniques. Current
methods limit researchers to testing samples one at a time (with microcalorimeters), and
the present approach has the additional advantage of being able to determine spatial
temperature distributions at any given time. This investigative technique could be more
powerful with higher performance infrared cameras with increased resolution.
2.4 Conclusion
An experimental approach for receptor activated cell heat detection that has been
designed, constructed, optimized, and successfully tested is described here. The thermal
inconsistencies initially found in the design were identified and rectified. The apparatus is
a tool to measure the temperature change of cells in a six well cell culture plate
immediately after the stimulant sample is introduced. This technique provides several
advantages over established microcalorimetric techniques and previously described
infrared techniques. Future designs could implement more sophisticated temperature
control units (such as a proportional/integrative/derivative controller) and a different
syringe heating design to allow for the use of cell plates with more wells. This type of
approach could be useful for quickly examining cellular metabolic effects of anti-obesity
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targets such as the ones disused in chapter one, or some combination thereof. The
creation and testing of different chemical modifications of known targets could lead to
different potential lead compounds but these variations must be tested for efficacy (Atgie,
Faintrenie et al. 1998; Kasuga, Nakagome et al. 2007).
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Chapter 3: Cell Tests
3.1 Introduction
Validation of the enclosure described in chapter 2 allowed for the testing of cell
cultures. 3T3-L1 adipocytes were treated with the most acute β3 agonist known, CL 316243, for a period of seven days in order to measure the potential increase in metabolic
capacity facilitated by the remodeling of the cells. To quantify and validate the cell
remodeling, the cells were stained with two fluorescent dyes; mitotracker deep red
(ex.644 em.665) and lipidtox green (ex. 495 em. 505). Fluorescence was measured using
flow cytometry and a fluorescence plate reader. Brightfiled images of the fixed cells were
also aquired as a qualitative indicator of the cell remodeling. Mitotracker deep red
intensities should increase after the treatment as the number of mitochondria is expected
to increase. Conversely, the lipidtox green intensity should decrease, as there should be
less fat in the cells.
3.2 Materials and Methods
The acute β3 agonist CL 316243 was used to treat 3T3-L1 adipocytes chronically
for seven days to bring about the previously described structural remodeling to modulate
the cells energy consumption profile and thereby increase the cells ability for
thermogenesis. The cells were monitored in the above-described set up using the same
protocol.
Murine 3T3-L1 preadipocytes were plated and grown 2 days past confluence in
Dulbecco’s modified Eagle’s medium (DMEM) and 10% bovine serum that was changed
every 48 hours. Differentiation of the cells into adipocytes was induced by changing the
media to DMEM with 10% fetal bovine serium (FBS), 0.5 mmol/l 3-isobutyl39

methylxanine, 1 µmol/l dexamethasone, and 1.7 µmol/l insulin (MDI). After 48 hours,
the DMEM-MDI was changed to DMEM and 10% FBS. This media was used through
the rest of experimentation. DMEM was purchased from Invitrogen (Carlsbad, CA). FBS
was purchased from Atlanta Biologicals (Lawrencevill, GA), and calf serum was
purchased from Invitrogen. DMEM and 10% FBS adipocyte media was used for
differentiated cells and was purchased from Zen-Bio (Research Triangle Park, NC).
Cells were treated with CL 316-243 (Sigma-Aldrich, ) on a seven-day treatment
program; with the final treatment reaction recorded using an infrared camera. This was
performed as constant or periodic measurements could introduce contamination to the
cells, (the cover of the cells is removed during imaging). Additionally, the aspiration of
media for prolonged periods during imaging could introduce undesirable artifacts. CL
treatments were administered in 10 µl aliquots at a concentration of 100 nM, with the
final treatment concentration being 25 µM due to the media aspiration for imaging. The
100 nM concentration was chosen to compare with a previous IR cell culture study
(Paulik, Buckholz et al. 1998).
The treatment and control vehicle was nano pure water. There could be osmotic
shock effects to the cells as a result of the treatments. These effects should be accounted
for in the experimental design, as control tests are done with the vehicle as well. It may
be beneficial in the future to use cell media as the vehicle to avoid osmotic shock issues.
Two cell plate configurations were tested, a normal 6 well plate and a 6 well
snapwell plate (Catalog # 07200708, Fischer Scientific, Pittsburg. PA). Snapwell plates
consist of a normal 6 well plate with small polyester membranes for cell growth that are
supported by a conical polycarbonate scaffold, such that the membrane suspends above
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the bottom of the well submerged in media. A lifting mechanism was fashioned out of
polycarbonate such that snapwell treated cells could remain in their media until they were
ready to be imaged. The lifting mechanism lifted the cells out of the media thus reducing
the heat transferred to the media and to the cell plate itself. Evaporative cooling is
minimized using a fourth peltier plate that resides in the upper insulation and evaporates a
small pool of water into the chamber increasing the humidity to approximately 75% and
the partial pressure of water in the environment. The snapwell plate was tested in order to
minimize the effects of conductive heat loss from the cells when they heat. It is
noteworthy that the cells grown in the snapwell plates receive the normal (100 nM) CL
dose during final injection because the media is not aspirated. Image analysis of the
snapwell plates is only done for the small insert; likewise, image analysis on the normal
plates is typically done on the area where treatment is applied, if the treatment does not
cover the entire well area.
The agonist and vehicle were loaded into the syringes, inserted into place and
allowed to equilibrate for 10 minutes. The cells were then aspirated and placed inside the
chamber and allowed to equilibrate for 10 minutes. The treatments and vehicle were
administered manually and power to the temperature control unit was turned off. Power
was turned off to avoid controlling the variable that was being measured (temperature).
Cells were imaged for ~30 minutes then discarded. Images were collected and analyzed
as described in Chapter 2. It is noteworthy that treatment typically covered 85 – 70% of
the cell well in the normal 6 well plates. These regions of treatment were gated and
measured. The snapwell plates were only measured on the small polyester membrane. It
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was assumed that the cells received a homogeneous CL treatment, as the molecular
weight of CL is small (465.79 g/mol).
To verify the effectiveness of the treatment, cells were stained with HCS lipidtox
green and mitotracker deep red (protocol in Appendix D) (Cat# H34475 and M22426,
Invitrogen Corporation, Grand Island, NY). The goal was to verify that the treatment with
CL over seven days was indeed bringing about the previously described remodeling of
the cells. By staining the Lipid droplets, which are expected to decrease in size, and the
mitochondria, which are expected to proliferate, a general indicator of remodeling could
be attained. The cells’ fluorescence intensity was measured using Flow cytometry
(FACSAria, BD Biosciences, San Jose, CA) and a plate fluorescence reader (FLUOstar
Optima, BMG Labtech, Offenburg, Germany). The flow cytometer excitation and
emission channels were set to 480 and 520, respectively for the lipidtox green and 650
and 680, respectively for the mitotracker red dyes.
An additional effort was made to quantify the treatment effects of the beta agonist
on the morphology of the cells. Brightfield images (20x) were taken of two cell plates
that received the same 0, 4, and 7-day treatments. These images were processed using an
image processing technique to quantify the number and size of lipid droplets by
thresholding bright areas. A single thresholding value was selected by averaging the
optimal value from six random images (two images from each treatment). Once the
average threshold value was selected it was applied to 9 random images from the two
plates for each treatment for a total of 27 images. The equivalent radius count, average
equivalent radius, equivalent radius standard deviation, and the maximum and minimum
equivalent radius were extracted from each thresholded image.
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3.3 Results
Brightfield imaging (Figure 14) shows that the cells appeared to go through the
remodeling, which produced somewhat smaller, leaner cells that should be more capable
of heat output (Granneman, Li et al. 2005). There appeared to be a fractioning of the
large adipose depots into smaller ones, however large droplets did not completely
separate. This morphology indicates a partial remodeling of unilocular to multilocular
depots.

0 day

7 day

Figure 14. Brihghtfield image of 3T3-L1 adipocytes on the 1st and 7th day of treatment at
40x. Notice the cells shift from unilocular to multilocular fat depots.
Fluorescent images were successful in staining targeted structures (Figure 15a).
Lipid droplets were clearly visible and the red mitochondrial stain was present and
visible, but appeared diffuse, which indicates that other structures may have also been
stained. Two concentrations of mitotracker red and lipidtox were initially tested. The
recommended concentration for the mitotracker red was 25-500 nM (Invitrogen product
sheet), The concentrations tested were 250 nM (Figure 15a) and 25 nM (Figure 15b).
The recommended lipidtox concentration was 1:200 (Invitrogen product sheet). The
concentrations tested were 1:400 (Figure 15b) and 1:200 (Figure 15a). The lipidtox was
clearly visible at both concentrations, whereas the lower mitotracker concentration was
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not (Figure 15b). The higher mitotracker concentration (250 nM) was visible (Figure
15a), but it appears to have lost mitochondrial specificity, as individual mitochondria are
not clearly discernable. A lower concentration, or shorter incubation time would be
required to achieve a good stain (Appendix D).

Figure 15. Fluorescent images of stained 3T3-L1 adipocytes with no CL treatment.
The fluorescence intensities increase from zero to four days of treatment, while
the 7 day treatment decreases for the 100 nM concentration and increases for the 200 nM
concentration (Figure 16). It is noteworthy that the detector was saturated (at 65000
relative fluorescence intensity units) in several samples of the lipidtox green samples.
The mitotracker deep red fluorescence intensities increased slightly through the
treatment, however this increase was not significant (Figure 17).
Image analysis of the brightfield images using average threshold values (1436)
yielded quantitative data on the number and size of lipid droplets (Table 2). The
equivalent radius (Re) was used to calculate the average radius, minimum and maximum
values. The total value is the product of the radius count and radius average. The average
count number of lipid droplets from the thresholded images showed higher values per
image for 4 and 7 day values, with the 4 day having the highest average count of 1594,
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just about the 7 day treatment count of 1576. The average equivalent radius shrunk
throughout the treatment from 0.77 µm for the 0 day to 0.45 µm for the 7 day.

Figure 16. Average Fluostar fluorescence intensities for Lipidtox green stained cells
treated with 100 and 200 nM concentrations of CL for 0, 4, and 7 days.
For infrared imaging results the average values for treatment and control in time
showed an upward trend in the 7-day treatment as expected (Figures 18 & 19), however
the large sample variance prevented the drawing of strong, statistically significant
conclusions from the results. For maximum temperatures measured, statistical
significance (p <0.05) between the test and control samples was only shown for the 4 day
treatment, (for both with and without snapwells) with the test being higher than the
control, as expected (Table 3). However, for the seven day treatment, the maximum
temperatures indicated only a tendency (p <0.10) for the test to be warmer than the
control (Table 3).
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Figure 17. Average fluostar fluorescence intensities for Mitotracker Deep Red stained
cells treated with 100 and 200 nM concentrations of CL for 0, 4 and 7 days.
Table 2. Quantitative results from thresholded images of 3T3-L1 cultured
adipocytes are shown.

The average temperature values also show a statistical tendency (p <0.10) for the tests to
be warmer than the control at 7 days for normal cell plates and at 4 days for snapwell
plates (Table 3). Additionally, it was shown that there was no statistical difference
between the control and the zero day treatment of both the snapwell and normal cell
plates (Table 3).
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Figure 18. Average temperatures of three treatment wells and three control wells injected
with vehicle. Standard deviation is plotted every 50 data points.

Figure 19. Average temperatures of three treatment snapwells and three control wells
injected with vehicle. Standard deviation is plotted every 50 data points.
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Table 3. T-test testing between control and treatment for each individual plate for
average and maximum temperatures. A * indicates statistical significance (p < 0.05), a 
highlight a tendency (p<0.10). SEM is standard error of the mean.
Snap

Time

N
N
N
Y
Y
Y

0
4
7
0
4
7

Ttreat
max
34.035
34.735
34.409
32.086
32.803
32.612

Tcontrol SEM
p
Max
33.755 0.10 0.11
34.532 0.04 0.03*
33.664 0.21 0.07
32.003 0.21 0.80
31.665 0.21 0.02*
31.838 0.39 0.24

Ttreat
Average
32.748
33.477
33.078
30.970
32.061
31.968

Tcontrol
Average
32.536
33.298
32.213
30.935
30.906
30.982

SEM

p

0.14
0.08
0.25
0.29
0.32
0.44

0.36
0.20
0.07
0.93
0.06
0.19

3.4 Discussion
3.4.1 Cell Remodeling
The initial staining of the cells not treated with CL with Mitotracker Deep Red
and HCS Lipidtox Green appeared to be successful (Figure 15) as there clearly red and
green regions of the cells that appeared to correspond to the specific structures. Analysis
of adipocytes that had been trypsinized was difficult because their high fat content made
them difficult to separate using conventional centrifugation. Fatty cells tended to float
and were difficult to separate from media via aspiration, as they tended to agglomerate to
the pipette tip. This resulted in low numbers of cells for analysis using flow cytometry.
Consequently, there was an insufficient volume to scan in the fluostar plate reader after
flow cytometry. Allowing the cells to remain attached permitted the use of the Fluostar
plate reader to measure fluorescence intensity. This data provided a quantitative measure
as to the degree of physical remodeling caused by CL treatment.
Lipidtox green fluorescence data was difficult to interpret. The quantification is
difficult because there are two different physical phenomenon that occur during the
remodeling process that could have different effects on fluorescence intensity. The first
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effect is the decrease in overall lipid content of the cells. This decrease should have the
effect of lowering fluorescence intensity. The second phenomenon that could affect
fluorescence intensity is the fractioning of lipid droplets into many smaller ones. This
changes the average surface-to-volume ratio, which could exert an upward pressure on
fluorescence intensities. These simultaneous and potentially conflicting effects could
account for the rising and then falling of lipidtox green fluorescence intensities observed
on the 100 nM treatment (Figure 16).
Another factor that could potentially affect the fluorescence intensity of the lipid
droplets is the focal plain used to measure the cells. Fluorescence intensity is strongly
dependant on the focal plain. The large differences in droplet size may lead them to
agglomerate in different focal plains (for example, smaller droplets might tend to
accumulate in one focal plain and larger droplets in another), generating a potential for
bias toward one morphology or another.
Mitotracker deep red fluorescence intensities were expected to gradually increase
over the duration of the treatment due to mitochondrial biogenesis. This increase was
observed in the data (Figure 17), but was not statistically significant due to a large
variance. It is unclear if mitochondrial stains were successful in selectively staining only
mitochondria, as the stain often appeared as a diffuse glow, rather than small distinct
glowing structures. This diffuse effect may also occur due to insufficient magnification
(higher magnification lenses were not available for adherent cells).
Image analysis of brightfield images of cells yielded quantitative data that
describes the remodeling of the cells (Table 2). The equivalent radius of the thresholded
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images were extracted and averaged for a total of 27 images (Appendix F). This
quantitative data describes the number and size of lipid droplets of all the cells in the

Figure 20. Fluorescent image of 3T3-L1 adipocytes treated with 200 nM Cl for 7 days.
image. The particle counts showed an increase in droplet numbers throughout the
treatments from 1290 on day 0 to 1593 on day 4 and finally, 1576 on day 7, as expected
and noted by previous studies (Granneman, Li et al. 2005). The complete dissolution of
small lipid droplets during the seven-day treatment could account for the slight decrease
from the 4th day to the 7th. The image analysis showed that the equivalent radius average
decreased over the course of the treatments from 0.77 µm on the zero day treatment to
0.58 µm on the fourth day treatment and finally, 0.45 µm on the seventh day. This shift in
the average equivalent radius indicates that the treatment created a change in the cells.
Additionally, the equivalent radius maximum decreased over the treatment indicating that
the larger droplets were not present in the treated cells. The maximum fell from 4.57 µm
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to 3.03 µm on the fourth day and then 2.42 µm on the seventh day of treatment. The
image analysis of brightfield images produced more conclusive quantitative results than
the fluorescent imaging that the cells underwent the remodeling process.
3.4.2 IR Results
The infrared images (Figures 21 & 22) show differential rates of heating in the
zero, four and seven day treatments. Heating above initial temperatures was observed in
most instances, but treatment wells seemed to heat faster although not significantly in all
cases. Contrary to the efforts described in the previous chapter, the control wells in some
instances appeared cooler then treatment wells before the final treatment (Figures 18 &
19). This was not expected, as up until this point, all of the wells for each plate have
received the same treatment/feeding schedule.

Figure 21. Infrared images of cell plates at zero day (a, b, c), 4 day (d, e, f) and 7 day
treatments (g, h, i) at time zero (a, d, g), ten minutes (b, e, h), and twenty minutes (c,
f, i) after injection. Treatment wells are on the right and control wells are on the left.
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Figure 22. Infrared images of snapwell cell plates at zero day (a, b, c), 4 day (d, e, f) and
7 day treatments (g, h, i) at time zero (a, d, g), ten minutes (b, e, h), and twenty
minutes (c, f, i) after injection. Treatment wells are on the right and control wells are
on the left.
Compiled data for both the snapwell and non-snapwell tests, ignoring differences
between treatment schedules and well types, showed a statistical significance (p < 0.05)
between the control and the treatment wells (see Appendix E). Additional testing could
determine if there was significance between different cell plate type and treatment
schedule. A t-test between treatment and control for each plate indicated that there was
no difference between treatment and control for the zero day tests for both the snapwell
and the normal plates (Table 3). This was in line with what was expected, as a unilocular
adipocyte should not typically posses the molecular machinery in sufficient quantities to
facilitate an appreciable (measurable) metabolic gain and thermogenic response upon
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stimulation. An unexpected finding was that the four-day treatment showed a slightly
higher average temperature than the seven-day treatment for all tests (Table 3).
Temperature increases of 0.86 °C were observed in this study using a standard 6 well
culture plate (Table 3), however due to a larger standard deviation, this increase is only a
statistical tendency (p < 0.10). The snapwell tests showed even larger differences, with a
max increase of 1.15 °C during the four-day test (Table 3). Additionally, the 4-day tests
showed significant heating over control (p < 0.05 for maximum well temperatures),
whereas the seven-day treatments only showed a tendency to heat more than controls
(Table 3). This was not expected, as the seven-day treatments were expected to have
more mitochondria and a higher expression of proteins associated with fatty acid
transport and breakdown, and therefore a greater thermogenic response. One possible
explanation of this is that beta 3 adrenoceptors are down regulated during stimulation
(Granneman and Lahners 1995; Klaus, Muzzin et al. 1995; Bengtsson, Redegren et al.
1996) and therefore the cells possessed fewer receptors by the 7th day of treatment.
One previous IR study on cell cultures examined heating effects on BAT resulting
from CL stimulation. Paulik et. al. found a 0.8°C increase in temperature over the control
(Paulik, Buckholz et al. 1998). There are several noteworthy differences between the
Paulik’s cell culture study and this one. The previous study used rotenone as a control,
which inhibits mitochondrial proton transport (Ahmad-Junan, Amos et al. 1994). This
should have provided for a cooler control than the vehicle tests reported here, as even
basal metabolism would come to a halt as the ATP was depleted. Temperature control of
injection allows for immediate measurement whereas in the previous study a ten minute
period was used to allow for equilibration. The methods used here turned off power to the
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temperature control device in order to prevent controlling what is being measured. This
study aspirated the media in larger 6 well plates, whereas the previous study cultured
cells in 96 well plates and allowed 50 µl/well to remain during imaging. The aspiration of
the media should allow for more precise kinetic analysis as the heat is not conducted
through the media in order to be measured. Also, aspiration of the media should allow for
detection of a larger temperature increase. It is likely that BAT measured using the
enclosure and method reported here would yield even larger temperature gains compared
to the previous study. It is noteworthy that the CL concentration of 100 nm was used in
both studies (Paulik, Buckholz et al. 1998).
3.5 Conclusions and Future Considerations
The data presented here indicates that there was a significantly higher temperature
for some samples of cultured adipocytes following CL treatment. Improvements to the
design and additional testing could provide more insight to the process. More robust cell
models could be used to take advantage of the higher throughput of these studies, and
additional thermal insulation and a more sophisticated control unit may provide more
significant results.
Future efforts to stain the cells to quantify the cell remodeling could utilize
different mitochondrial stains that change florescence intensity depending on
mitochondrial activity, such as JC-1 or rhodamine derivatives (Reers, Smith et al. 1991).
This dynamic fluorescence would provide a fast direct measurement of change within the
cell. Measurements with mitochondrial reactive dyes would be an interesting addition to
this work but not a substitute for direct temperature measurement, as these dyes have a
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high degree of non-specific staining, and therefore introduce background noise. The dyes
can also be cytotoxic or might be metabolized by the cells.
The enclosure and thermal control of both the cells and the treatments is what
differentiates these studies from those previously reported. The thermal control of the
injection temperatures allows for immediate temperature measurement after injection and
could offer new insight into the kinetics of thermogenesis. A larger population of trials
would be necessary to establish more significant trends in heating. To accommodate cell
plates with more wells would only require a redesigned set of injection blocks. The
geometry of new injection block would require a careful design, as plates with more
wells would necessitate syringes that protrude farther into the interior of the enclosure.
While chapter 2 established that there was no difference in the averages between
treatment and control wells, the larger variance of the control side implies that further
measures could be used to completely insulate the cells. This could be accomplished by
adding insulation to the enclosure, or by placing the enclosure itself inside of a thermally
monitored environment. It is noteworthy that lab temperature fluctuated considerably,
and that those fluctuations did affect chamber temperature, so it is likely that the design
could benefit from further thermal insulation.
The down-regulation of the β3 receptors during stimulation could present a
challenge to the development of a beta adrenoceptor anti-obesity drug. Additional
challenges to the use of this target include the elevated plasma FFA levels resulting from
lipid transport out of WAT that may be detrimental to health. Because of this, it seems
that β3 adrenergic stimulation alone would not be a desirable treatment modality for
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obesity. It is likely that some combination of targets would have more beneficial
outcomes.
In general, the recent advances of infrared imaging technology have increased the
capability of this type of temperature measurement systems at greatly reduced cost.
Previous research and the study described here is likely only the beginning of IR
technology uses in biotechnology. Agricultural and food bioprocess IR imaging
applications as well as clinical applications have been investigated (Chaerle 2000; Jones
2002; Lenhard 2006; Gerbo 2008). Future improvements to the above described model
and technique would likely yield better and more precise information.
The spatial resolution of IR thermography has several benefits. The image
processing software reports the hottest or coldest temperature or the average in a defined
area of the image, all of which can be performed in real time, post processing or both.
This is a significant advantage over thermocouple temperature measurement in situations
where the maximum or minimum temperatures of a system may be desired, but can not
be easily located. Performing these tasks in post processing allows for data to be analyzed
many different ways without the need for moving sensors or replicating experiments.
The spatial resolution of IR thermography could potentially be very useful in
studies investigating effects of autocrine signaling (signals from adipocytes to other
adipocytes) on adipocyte metabolism. WAT is known to secrete a series of adipokines,
17 of which are thought to have an autocrine function (Wang, Mariman et al. 2008).
These studies could take advantage of the spatial resolution of IR thermography by
observing effects on peripheral cells caused by other adipocytes secreting adipokines.
Additionally, it may be possible to culture adipocytes with other cell types to measure
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endocrine or paracrine functions. This would be an excellent application for the snapwell
plates, as one type of cell could be cultured in the bottom of the well and the adipocytes
could be cultured separately in the snapwell insert. This configuration could
accommodate the special growth or treatment requirements of different types of cells
while allowing for a common environment for signaling and measuring by simply
moving the insert.
In addition to the above-described applications, a system is envisioned that would
take advantage of the onboard processing and logic output capabilities of today’s
cameras. Selective hyperthermia using photothermal ablation has been suggested as a
possible cancer treatment with the aid of chromophores that selectively accumulate in
cancer tissue and are easily heated by lasers or other electromagnetic stimulation.
Infrared thermography has shown to be useful for measuring temperature changes of
carbon nanotubes (Boldor, Gerbo et al. 2008). A proposed sensitizer could therefore
prove to be a useful method of laser dosage control in the eventual clinical manifestation
of these treatments. Current models of IR cameras have real time analysis software and
can be integrated with specialized software packages such as Labview (National
Instruments, Austin, TX) and built in controllers. It is easy to envision a system whereby
skin temperature is used as a feedback in a control circuit for laser ablation of tissue in a
clinical setting. More complex techniques of control feedback equations could be
developed to incorporate sophisticated IR techniques such as lock in thermography for
increased sensitivity and for use with lasers that have a higher penetration depth such as
the Nd:YAG and other diode lasers currently being developed.
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Appendix A: VBA Macro for Infrared Image Extraction in Excel

Sub macro()
Dim sess As Object
Dim row As Integer
Dim col As Integer
row = 3
col = 2
'get a reference to the termacam research object
Set sess = _Worksheets("Sheet1").OLEObjects("Object 1").Object
' Move to the first image in the session
sess.GotoFirstImage
' Start a loop that iterates through all images in the session
Do While True
' Store IR images time and spotmeter temperatures in the cells
Worksheets(2).Cells(row, col).Value = _sess.GetNamedValue("AR01.max")
Worksheets(2).Cells(row, col + 1).Value = _sess.GetNamedValue("AR01.avg")
If sess.IsLastImage Then
Exit Do
End If
sess.Stepforward
row = row + 1
Loop
End Sub
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Appendix B: Basic Stamp Program for Temperature Control

' $STAMP BS2p
' $PORT COM1
result1 VAR Word
AvgResult1 VAR Word
result2 VAR Word
AvgResult2 VAR Word
result3 VAR Word
AvgResult3 VAR Word
i VAR Byte
Main:
GOSUB Test1
GOSUB Check1
GOSUB Test2
GOSUB Check2
GOSUB Test3
GOSUB Check3
GOTO Main
Check1:
IF AvgResult1 > 1650 THEN Relay1On
IF AvgResult1 < 1650 THEN Relay1Off
RETURN

'red #2

Check2:
'this is for the center plate and is thermocouple #1
IF AvgResult2 > 1270 THEN Relay2On
IF AvgResult2 < 1270 THEN Relay2Off
RETURN
Check3:
IF AvgResult3 > 1530 THEN Relay3On
IF AvgResult3 < 1530 THEN Relay3Off
RETURN

'green #3

Relay1On:
DEBUG "Relay1 ON",CR
HIGH 3
HIGH 6
RETURN
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Relay1Off:
DEBUG "Relay1 OFF",CR
LOW 3
LOW 6
RETURN
Relay2On:
DEBUG "Relay2 ON",CR
HIGH 4
HIGH 7
RETURN
Relay2Off:
DEBUG "Relay2 OFF",CR
LOW 4
LOW 7
RETURN
Relay3On:
DEBUG "Relay3 ON",CR
HIGH 5
HIGH 8
RETURN
Relay3Off:
DEBUG "Relay3 OFF",CR
LOW 5
LOW 8
RETURN
Test1:
FOR i = 1 TO 10
HIGH 15
' charge the cap
PAUSE 1
' for 1 ms
RCTIME 15, 1, result1
AvgResult1 = AvgResult1 + result1
NEXT
AvgResult1 = AvgResult1/10
DEBUG DEC ? AvgResult1
' display result
RETURN
Test2:
FOR i = 1 TO 10
HIGH 14

' charge the cap
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PAUSE 1
' for 1 ms
RCTIME 14, 1, result2
AvgResult2 = AvgResult2 + result2
NEXT
AvgResult2 = AvgResult2/10
DEBUG DEC ? AvgResult2
RETURN
Test3:
FOR i = 1 TO 10
HIGH 13
' charge the cap
PAUSE 1
' for 1 ms
RCTIME 13, 1, result3
AvgResult3 = AvgResult3 + result3
NEXT
AvgResult3 = AvgResult3/10
DEBUG DEC ? AvgResult3
RETURN
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Appendix C: Protocol for Treating and Imaging Cells

Materials:
6 well Cell plates
Adipocyte Media (2.5 ml /well) - aliquot into 50 ml centrifuge tube (Fischer Scientific)
10ml pipettes (2 for just feeding - more if cells are treated and you wish to avoid
contamination of treatment – 4 total for 3 plates)
cell waste beaker
25 µM Cl 316 243 solution for treatment (Sigma Aldrich)
10 ul pipette tips
CL treatment and Feeding Procedure:
1) Make sure hood vent is turned ON then pull open the hood and allow it to run
for 5 minutes
2) Wipe down area under hood thoroughly
3) Gather ALL required materials and place them under the hood
4) Aspirate media starting with control cells then aspirate treatment cells with
10ml pipettes to avoid contamination
5) With a new pipette, add 2.5 ml of new media being careful not to touch the cell
well with the tip of the pipette. If this happens, discard your pipette and get a new
one. This will help avoid contamination of the media.
6) For treatment, vortex or shake the 25 µM CL 316 243 stock and then add 10 µl
to each well being treated being sure to clearly mark which plates are treated and
which ones are not
7) Replace cells in incubator and clean all surfaces thoroughly and put media back
in the refrigerator and clean the cell beaker with soap and bleach
Treatment and Imaging Procedure:
1) Turn on the electronic control unit and allow it to equilibrate overnight.
2) Examine the temperature measurement system to ensure that all plate
temperatures have equilibrated. An adjustment to the control units code may
be required.
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3) Turn on the IR camera and allow it to equilibrate for 20 minutes. Check to
ensure that it is properly focused and that the emissivity is set to 0.98.
4) Once the temperatures are equilibrated, aspirate the media of the cell wells
and load it in the chamber. Close the chamber
5) Load the injection syringes with 10 µl of the treatment or control media.
6) Allow the system to equilibrate for about 10 minutes.
7) Start recording using the digital control software, and press the syringed to
inject the samples. Retract the sample injection blocks from the field of view
of the camera and turn off the electronic power supply to the peltier plates.
For snapwell plates, insert the polycarbonate lifting mechanism to lift the cells
from the media.
8) Allow the system to record as many samples as desired.
9) Stop Recording.
10) Power on the electronic control circuit so the system can heat back up.
11) Remove the cell plate and discard.
12) Once the set up temperature has re equilibrated, repeat steps 4-12 until all
plates have been recorded.
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Appendix D: Protocol for Staining and Measuring Fluourescense Intensity

This is a protocol for dual labeling 3t3-l1 cells to selectively stain the
mitochondria and the fat depots. This will be useful for quantifying the remodeling of the
cells subject to beta-adrenergic agonists using flow cytometry and a fluorescence plate
reader. The expected effect of the treatment is an increase in the number of mitochondria
and a decrease in the size of lipid depots.
Required materials:
Cells – in six or twelve well plates
DMSO
DMEM or adipocyte media
PBS
0.25% Tripsin 1X
Formaldehyde
HCS lipidtox green
Mitotracker deep red
Falcon flow cytometry tubes
Paraformaldehyde 1%
1ml pipette and tips
1.5ml eppendorf tubes
Part 1: Mitotracker Staining
Preparing stock solutions:
Before opening vial, allow the product to warm to room temperature. To prepare the
stock solution, dissolve the lyophilized product in high-quality, anhydrous dimethylsulfoxide (DMSO) to a final concentration of 1 mM. You can store the frozen stock at <20 C and protect from light.
1.1 Dilute the 1 mM stock solution to the final working concentration in growth
medium (DMEM or adipocyte media). For live cell staining concentrations of 25‐
500 nM are recommended for fixed cells higher concentrations are
recommended (100‐500nM). The concentration should be as low as possible to
avoid artifacts and overlap.
The mitotracker comes in 50 µg tubes and has a molecular weight of 543.58. SO
to make a 1 mM stock you should add the 50 µg to:

91.8 µl of DMSO.
Staining two twelve well plates with 0.6 ml of solution in each well will require 14.4 ml
of 25nM solution. This will require 0.36 µl of 1mM stock solution (to make 15 ml use
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.375 µl). To avoid doing serial dilutions, you could use 1 µl in 40 ml of solution for a 25
nm solution.
1.2 Remove media from grown cells and replace with the media with the mitotracker
label. This media should be pre-warmed to 37 C. Incubate the cells for 15-45 minutes in
the incubator.
1.3 Replace media and dye with fresh pre warmed media and observe the cells under the
microscope. Cells may require higher concentrations or longer incubation times.
Part 2: Harvesting and fixing the cells.
A. Observe and take brightfield images of cells seeded in 12mm-cell culture dishes before
harvesting (to ensure uniform cell density among all wells).
B. Harvest cells
1) Aspirate
2) Wash with 0.6 mL PBS
3) Add 0.6 mL 0.25% trypsin.
i. Allow 5-7 minutes for cells to detach from the bottom of the dish.
4) Add 0.6 mL of DMEM-RS (+3% FBS)
5) Transfer cells in solution to 1.5mL eppendorf tube using 1mL pipettor (or 5 mL
cytometer tube using transfer pipet)
6) Spin down at 1,800 rpm for 5 minutes on big centrifuge (or 2,400 rpm on minispin)
7) Aspirate carefully using 1 mL pipettor
C. Wash procedure
1) Resuspend the cells in 600 µL DMEM-RS+FBS
2) Spin down at 1,800 rpm for 5 minutes on big centrifuge (or 2,400 rpm on minispin)
3) Aspirate carefully using 1 mL pipettor

D. Fixing cells
1) Add 300 µL 1% PFA (paraformaldehyde) in buffer to each tube
2) Incubate for 10‐30 minutes at room temperature
E. Wash procedure
1) Resuspend the cells in 600 µL DMEM-RS+FBS
2) Spin down at 1,800 rpm for 5 minutes on big centrifuge (or 2,400 rpm on minispin)
3) Aspirate carefully using 1 mL pipettor
F. Wash procedure
1) Resuspend the cells in 600 µL DMEM-RS+FBS
2) Spin down at 1,800 rpm for 5 minutes on big centrifuge (or 2,400 rpm on minispin)
3) Aspirate carefully using 1 mL pipettor

Part 3: Lipidtox Staining
3.1 Dilute the LipidTOX™ neutral lipid stain 1:200 in buffer. Prepare a volume
sufficient to completely cover cells.
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Note: The 1:200 dilution is a recommended starting point. It may be necessary to
optimize the dilution for your system. You should have this dilution before starting
this procedure.
3.2 Add LipidTOX™ neutral lipid stain and incubate the cells at room temperature
for at least 30 minutes before imaging.
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Appendix E: SAS Code for Compiled Data
The Mixed Procedure
Model Information
Data Set
Dependent Variable
Covariance Structure
Estimation Method
Residual Variance Method
Fixed Effects SE Method
Degrees of Freedom Method

WORK.TWO
tavg
Diagonal
REML
Profile
Model-Based
Residual

Class Level Information
Class
WelType
Time
Treat
well

Levels

Values

2
3
2
6

Snap nonsnap
0 3 7
Treat control
1 2 3 4 5 6
Dimensions

Covariance Parameters
Columns in X
Columns in Z
Subjects
Max Obs Per Subject

1
31
0
1
36

Number of Observations
Number of Observations Read
Number of Observations Used
Number of Observations Not Used

36
36
0

Covariance Parameter Estimates
Cov Parm

Estimate

Standard
Error

Z
Value

Pr Z

Residual

0.2349

0.06782

3.46

0.0003

Fit Statistics
-2 Res Log Likelihood
AIC (smaller is better)
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46.5
48.5

There is a treatment effect (p-value
is less then 0.05). Therefore, I think
you are fine doing only a 2nd run
2008 rd51
and not
a 3 . I would do the 2nd run
no matter what because your
treatment effect is not constant
across time and plate type. Look at
the means below. By having a 2nd
run you might be able to detect
some of those interactions as
significant.

The SAS System

16:05 Thursday, January 24,

The Mixed Procedure
Fit Statistics
AICC (smaller is better)
BIC (smaller is better)

48.7
49.7

Do not use!! Tested vs.
wrong error term.

Type 3 Tests of Fixed Effects

Effect

Num
DF

Den
DF

F Value

Pr > F

2
1
2
1
2

24
24
24
24
24

1.82
12.56
2.13
0.91
1.14

0.1838
0.0017
0.1408
0.3498
0.3367

WelType*Time
Treat
Time*Treat
WelType*Treat
WelType*Time*Treat

Least Square Means
Effect
> |t|
Treat
<.0001
Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001
WelType*Time*Treat
<.0001

WelType

Estimate

Standard
Error

DF

t Value

Treat

32.3836

0.1142

24

283.45

control

31.8111

0.1142

24

278.44

Treat

Time

Snap

Treat

0

30.9703

0.2799

24

110.67

Snap

control

0

30.9316

0.2799

24

110.53

Snap

Treat

3

32.0611

0.2799

24

114.57

Snap

control

3

30.9055

0.2799

24

110.44

Snap

Treat

7

31.9678

0.2799

24

114.23

Snap

control

7

30.9823

0.2799

24

110.71

nonsnap

Treat

0

32.7477

0.2799

24

117.02

nonsnap

control

0

32.5362

0.2799

24

116.26

nonsnap

Treat

3

33.4766

0.2799

24

119.62

nonsnap

control

3

33.2979

0.2799

24

118.98

nonsnap

Treat

7

33.0778

0.2799

24

118.20

nonsnap

control

7

32.2128

0.2799

24

115.11

Pr

I have a question: I thought that at time 0 you should see some treatment
differences, but you don’t with either of the plate’s type (snap vs. nonsnap).
If you are not suppose to see a difference at time 0 between trt. and ctr., let me
know because we should treat it in a different way. Basically not include time
0 into the model.
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The SAS System
2008

16:05 Thursday, January 24,

52
The UNIVARIATE Procedure
Variable: Resid (Residual)
Moments
N
Mean
Std Deviation
Skewness
Uncorrected SS
Coeff Variation

36
0
0.40138204
-0.4371074
5.6387639
.

Sum Weights
Sum Observations
Variance
Kurtosis
Corrected SS
Std Error Mean

36
0
0.16110754
0.84393048
5.6387639
0.06689701

Basic Statistical Measures
Location
Mean
Median
Mode

Variability

0.00000
-0.00695
.

Std Deviation
Variance
Range
Interquartile Range

0.40138
0.16111
1.84040
0.47190

Tests for Location: Mu0=0
Test

-Statistic-

-----p Value------

Student's t
Sign
Signed Rank

t
M
S

Pr > |t|
Pr >= |M|
Pr >= |S|

0
0
9

1.0000
1.0000
0.8899

Tests for Normality
Test

--Statistic---

-----p Value------

Shapiro-Wilk
Kolmogorov-Smirnov
Cramer-von Mises
Anderson-Darling

W
D
W-Sq
A-Sq

Pr
Pr
Pr
Pr

0.958744
0.077157
0.033157
0.31705

Quantiles (Definition 5)
Quantile

Estimate

100% Max
99%
95%
90%
75% Q3

0.64612424
0.64612424
0.63627347
0.57879949
0.23490065
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<
>
>
>

W
D
W-Sq
A-Sq

0.1966
>0.1500
>0.2500
>0.2500

The SAS System
2008

16:05 Thursday, January 24,

53
The UNIVARIATE Procedure
Variable: Resid (Residual)
Quantiles (Definition 5)
Quantile

Estimate

50% Median
25% Q1
10%
5%
1%
0% Min

-0.00695232
-0.23700375
-0.46336996
-0.54805172
-1.19427112
-1.19427112

Extreme Observations
------Lowest------

------Highest-----

Value

Obs

Value

Obs

-1.194271
-0.548052
-0.496776
-0.463370
-0.437127

30
17
15
34
3

0.554328
0.578799
0.615472
0.636273
0.646124

36
28
29
16
4

Stem
6
4
2
0
-0
-2
-4
-6
-8
-10

Leaf
245
3158
96
003606678
97399922
5553
50640

#
3
4
2
9
8
4
5

9
1
----+----+----+----+
Multiply Stem.Leaf by 10**-1

Boxplot
|
|
+-----+
| + |
*-----*
+-----+
|
0

The UNIVARIATE Procedure
Variable: Resid (Residual)
Normal Probability Plot
0.7+
*+*++ *
|
***+*+
|
++**+
0.1+
*******
|
******
|
****+
-0.5+
* *+*+**
|
+++++
| +++++
-1.1++
*
+----+----+----+----+----+----+----+----+----+----+
-2
-1
0
+1
+2
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Appendix F: Brightfield Images for Quantitative Analysis

Zero Day Images
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Four day images
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Seven Day Images
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